These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7927849)

  • 1. Teaching individualized antibiotic dosage regimens by means of two computer-assisted learning programs.
    Le Normand Y; Drugeon HB; Potel G; Kergueris MF; Raffi F; Milpied N; Douet MC; Caillon J; Roźe JC
    Int J Biomed Comput; 1994 Jun; 36(1-2):117-9. PubMed ID: 7927849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An example of simulation for a better understanding of PK/PD relationship of antibiotics].
    Le Normand Y; Ganiere-Monteil C; Drugeon H; Abbas S; Mazeas M; Kergueris MF
    Pathol Biol (Paris); 2004 Dec; 52(10):597-601. PubMed ID: 15596309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.
    Frymoyer A; Stockmann C; Hersh AL; Goswami S; Keizer RJ
    J Pediatric Infect Dis Soc; 2019 May; 8(2):97-104. PubMed ID: 29294072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
    Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of a vancomycin loading dose in children.
    Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
    Wragge TM; Cooper BE
    Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in vancomycin pharmacokinetics in critically ill infants.
    Gous AG; Dance MD; Lipman J; Luyt DK; Mathivha R; Scribante J
    Anaesth Intensive Care; 1995 Dec; 23(6):678-82. PubMed ID: 8669599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.